Skip to main content

Advertisement

SpringerLink
Log in

p53 Mutations are Associated with Dysplasia and Progression of Dysplasia in Patients with Crohn’s Disease

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background: Mutations in the tumor suppressor gene p53 are associated with neoplasia in ulcerative colitis, but little is understood of their significance in Crohn’s disease (CD). Purpose: To explore p53 expression as a marker of neoplasia in CD patients. Methods: This is a retrospective review of CD patients who underwent p53 IHC staining in our center between 1995 and 2003. The p53 status was correlated to the presence and grade of neoplasia at the time of staining and in subsequent follow-up. Results: Fourteen CD patients had p53 assessment: eight were p53 positive and six were p53 negative. Seven of eight p53+ had dysplasia (six LGD, one HGD); one of six p53−had dysplasia (LGD) (P = 0.03). Four p53+ patients with follow-up had persistent dysplasia and two had progression to a higher grade. Three p53− patients with follow-up remained free of dysplasia. Conclusions: This limited study shows that p53 over expression in CD patients is associated with dysplasia that may progress to a higher grade of neoplasia over time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228–1233

    Article  PubMed  CAS  Google Scholar 

  2. Ekbom A, Helmick C, Zack M, Adami HO (1990) Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 336:357–359

    Article  PubMed  CAS  Google Scholar 

  3. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN (1994) Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35:1590–1592

    Article  PubMed  CAS  Google Scholar 

  4. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100:2724–2729

    Article  PubMed  Google Scholar 

  5. Sachar DB (1994) Cancer in Crohn’s disease: dispelling the myths. Gut 35:1507–1508

    Article  PubMed  CAS  Google Scholar 

  6. Itzkowitz S (2003) Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol 36:S70–S74 discussion S94–S96

    Article  PubMed  CAS  Google Scholar 

  7. Lane DP (1992) Cancer. p53, guardian of the genome Nature 358:15–16

    Article  PubMed  CAS  Google Scholar 

  8. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53

    Article  PubMed  CAS  Google Scholar 

  9. Carson DA, Lois A (1995) Cancer progression and p53. Lancet 346:1009–1011

    Article  PubMed  CAS  Google Scholar 

  10. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532

    Article  PubMed  CAS  Google Scholar 

  11. Lashner BA, Bauer WM, Rybicki LA, Goldblum JR (2003) Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Am J Gastroenterol 98:1423–1427

    PubMed  CAS  Google Scholar 

  12. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, Burmer GC (1994) Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107:369–378

    PubMed  CAS  Google Scholar 

  13. Ajioka Y, Watanabe H, Matsuda K (1995) Over-expression of p53 protein in neoplastic changes in ulcerative colitis: immunohistochemical study. J Gastroenterol 30(Suppl 8):33–35

    PubMed  Google Scholar 

  14. Burmer GC, Crispin DA, Kolli VR, Haggitt RC, Kulander BG, Rubin CE, Rabinovitch PS (1991) Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis. Cancer Commun 3:167–172

    PubMed  CAS  Google Scholar 

  15. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE (1992) Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 103:1602–1610

    PubMed  CAS  Google Scholar 

  16. Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, McDaniel T, Newkirk C, Resau JH, Meltzer SJ (1992) Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 52:741–745

    PubMed  CAS  Google Scholar 

  17. Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR, Laurin JN, Abraham JM, Greenwald BD, Meltzer SJ (1994) p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 25:1069–1074

    Article  PubMed  CAS  Google Scholar 

  18. Taylor HW, Boyle M, Smith SC, Bustin S, Williams NS (1993) Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis. Br J Surg 80:442–444

    Article  PubMed  CAS  Google Scholar 

  19. Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwald BD, Hontanosas M, Newkirk C, Meltzer SJ (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104:1633–1639

    PubMed  CAS  Google Scholar 

  20. Ilyas M, Talbot IC (1995) p53 expression in ulcerative colitis: a longitudinal study. Gut 37:802–804

    Article  PubMed  CAS  Google Scholar 

  21. Holzmann K, Klump B, Borchard F, Hsieh CJ, Kuhn A, Gaco V, Gregor M, Porschen R: (1998) Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int J Cancer 76:1–6

    Article  PubMed  CAS  Google Scholar 

  22. Sato A, MacHinami R (1999) p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma. Pathol Int 49:858–868

    Article  PubMed  CAS  Google Scholar 

  23. Lashner BA, Shapiro BD, Husain A, Goldblum JR (1999) Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol 94:456–462

    Article  PubMed  CAS  Google Scholar 

  24. Warren S, Sommers S (1948) Cicatrizing enteritis (regional enteritis) as a pathologic entity: analysis of one hundred and twenty cases. Am J Pathol 24:475–501

    CAS  PubMed  Google Scholar 

  25. Persson PG, Karlen P, Bernell O, Leijonmarck CE, Brostrom O, Ahlbom A, Hellers G: (1994) Crohn’s disease and cancer: a population-based cohort study. Gastroenterology 107:1675–1679

    PubMed  CAS  Google Scholar 

  26. Gillen CD, Andrews HA, Prior P, Allan RN (1994) Crohn’s disease and colorectal cancer. Gut 35:651–655

    Article  PubMed  CAS  Google Scholar 

  27. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN (1980) Malignancy in Crohn’s disease. Gut 21:1024–1029

    Article  PubMed  CAS  Google Scholar 

  28. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF (1973) Crohn’s disease and cancer. N Engl J Med 289:1099–1103

    Article  PubMed  CAS  Google Scholar 

  29. Kilgore SP, Sigel JE, Goldblum JR (2000) Hyperplastic-like mucosal change in Crohn’s disease: an unusual form of dysplasia? Mod Pathol 13:797–801

    Article  PubMed  CAS  Google Scholar 

  30. Koda K, Yoshino G, Honda S, Watanabe F, Sugimura H (2000) Adenocarcinoma of the rectum with various grades of atypia in association with Crohn’s disease: a case report and immunohistochemistry of p53 and Ki-67. Pathol Int 50:318–326

    Article  PubMed  CAS  Google Scholar 

  31. Tiszlavicz L, Kapin M, Varkonyi A, Lorincz A, Bartyik K, Varkonyi T (2001) Adenocarcinoma of the colon developing on the basis of Crohn’s disease in childhood. Eur J Pediatr 160:168–172

    Article  PubMed  CAS  Google Scholar 

  32. Fogt F, Vortmeyer AO, Goldman H, Giordano TJ, Merino MJ, Zhuang Z (1998) Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma. Hum Pathol 29:131–136

    Article  PubMed  CAS  Google Scholar 

  33. Sjoqvist U, Befrits R, Soderlund S, Ost A, Karlen P, Tribukait B, Rubio C, Rutgeerts P, Geboes K, Lofberg R (2005) Colorectal cancer in colonic Crohn’s disease–high frequency of DNA-aneuploidy. Anticancer Res 25:4393–4397

    PubMed  CAS  Google Scholar 

  34. Lofberg R, Brostrom O, Karlen P, Ost A, Tribukait B (1991) Carcinoma and DNA aneuploidy in Crohn’s colitis–a histological and flow cytometric study. Gut 32:900–9004

    Article  PubMed  CAS  Google Scholar 

  35. Markowitz J, McKinley M, Kahn E, Stiel L, Rosa J, Grancher K, Daum F (1997) Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis. Am J Gastroenterol 92:2001–2006

    PubMed  CAS  Google Scholar 

  36. Heinzlmann M, Lang SM, Neynaber S, Reinshagen M, Emmrich J, Stratakis DF, Heldwein W, Wiebecke B, Loeschke K (2002) Screening for p53 and K-ras mutations in whole-gut lavage in chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 14:1061–1066

    Article  PubMed  CAS  Google Scholar 

  37. Lofberg R, Brostrom O, Karlen P, Ost A, Tribukait B (1992) DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 102:1149–1154

    PubMed  CAS  Google Scholar 

  38. Lindberg JO, Stenling RB, Rutegard JN (1999) DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis. Br J Surg 86:947–950

    Article  PubMed  CAS  Google Scholar 

  39. Befrits R, Hammarberg C, Rubin CE (1994) DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis: A 10-year follow-up study. Dis Colon Rectum 37:313–320

    Article  PubMed  CAS  Google Scholar 

  40. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, Dean PJ, Kimmey M, Perera DR, Rabinovitch PS (1992) DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103:1611–1620

    PubMed  CAS  Google Scholar 

  41. Karlen P, Young E, Brostrom O, Lofberg R, Tribukait B, Ost K, Bodian C, Itzkowitz S (1998) Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy. Gastroenterology 115:1395–1404

    Article  PubMed  CAS  Google Scholar 

  42. Itzkowitz SH, Young E, Dubois D, Harpaz N, Bodian C, Chen A, Sachar DB (1996) Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. Gastroenterology 110:694–704

    Article  PubMed  CAS  Google Scholar 

  43. Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner MP (2000) The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol 157:737–745

    PubMed  CAS  Google Scholar 

  44. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland CR (1996) Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 56:1237–1240

    PubMed  CAS  Google Scholar 

  45. Heinen CD, Noffsinger AE, Belli J, Straughen J, Fischer J, Groden J, Fenoglio-Preiser CM (1997) Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation. Genes Chromosomes Cancer 19:170–175

    Article  PubMed  CAS  Google Scholar 

  46. Fleisher AS, Esteller M, Harpaz N, Leytin A, Rashid A, Xu Y, Liang J, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Wilson KT, James SP, Herman JG, Meltzer SJ (2000) Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 60:4864–4868

    PubMed  CAS  Google Scholar 

  47. Eaden JA, Mayberry JF (2002) Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51 Suppl 5:V10–V12

    Google Scholar 

  48. Itzkowitz SH (1997) Inflammatory bowel disease and cancer. Gastroenterol Clin North Am 26:129–139

    Article  CAS  Google Scholar 

  49. Vemulapalli R, Lance P (1994) Cancer surveillance in ulcerative colitis: more of the same or progress? Gastroenterology 107:1196–1199

    PubMed  CAS  Google Scholar 

  50. Lynch DA, Lobo AJ, Sobala GM, Dixon MF, Axon AT (1993) Failure of colonoscopic surveillance in ulcerative colitis. Gut 34:1075–1080

    Article  PubMed  CAS  Google Scholar 

  51. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH (1994) Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107:934–944

    PubMed  CAS  Google Scholar 

  52. Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343:71–74

    Article  PubMed  CAS  Google Scholar 

  53. van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB (2002) Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl (236):48–53

  54. Munkholm P, Langholz E, Davidsen M, Binder V (1993) Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology 105:1716–1723

    PubMed  CAS  Google Scholar 

  55. Bernstein CN, Blanchard JF, Kliewer E, Wajda A (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854–862

    Article  PubMed  CAS  Google Scholar 

  56. Ekbom A, Helmick C, Zack M, Adami HO (1991) Extracolonic malignancies in inflammatory bowel disease. Cancer 67:2015–2019

    Article  PubMed  CAS  Google Scholar 

  57. Gollop JH, Phillips SF, Melton 3rd LJ, Zinsmeister AR (1988) Epidemiologic aspects of Crohn’s disease: a population based study in Olmsted County, Minnesota, 1943–1982. Gut 29:49–56

    Article  PubMed  CAS  Google Scholar 

  58. Petras RE, Mir-Madjlessi SH, Farmer RG (1987) Crohn’s disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 93:1307–1314

    PubMed  CAS  Google Scholar 

  59. Richards ME, Rickert RR, Nance FC (1989) Crohn’s disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg 209:764–773

    Article  PubMed  CAS  Google Scholar 

  60. Uesugi H, Mitomi H, Sada M, Takahashi H, Kobayashi K, Igarashi M, Katsumata T, Ihara A, Ohtani Y, Ikeda S, Okayasu I (1999) A case of adenocarcinoma of the small intestine in a Japanese patient with Crohn disease: a report with immunohistochemical and oncogenic analyses. Scand J Gastroenterol 34:1162–1167

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

Supported in part by the University of Chicago Digestive Disease Research Core Center, NIH grant P30 DK42086.

Author information

Authors and Affiliations

  1. Reva and David Logan Gastrointestinal Clinical Research Center at the University of Chicago, Chicago, IL, USA

    Jeffrey W. Nathanson, Nicole E. Yadron, Jeanne Farnan, Sydney Kinnear, John Hart & David T. Rubin

  2. Gastroenterology, University of Chicago Medical Center, 5841 S. Maryland Ave., Chicago, IL, 60637, USA

    David T. Rubin

Authors
  1. Jeffrey W. Nathanson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicole E. Yadron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeanne Farnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sydney Kinnear
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John Hart
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David T. Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David T. Rubin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nathanson, J.W., Yadron, N.E., Farnan, J. et al. p53 Mutations are Associated with Dysplasia and Progression of Dysplasia in Patients with Crohn’s Disease. Dig Dis Sci 53, 474–480 (2008). https://doi.org/10.1007/s10620-007-9886-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-007-9886-1

Keywords

Search

Navigation